Published Application/Species/Sample/Dilution | Reference |
---|
- western blot; human; 1:500; loading ...; fig 5a
| Loureiro J, Raimundo L, Calheiros J, Carvalho C, Barcherini V, Lima N, et al. Targeting p53 for Melanoma Treatment: Counteracting Tumour Proliferation, Dissemination and Therapeutic Resistance. Cancers (Basel). 2021;13: pubmed publisher
|
- western blot; human; 1:1000; loading ...; fig 5j
| Chen G, Liu B, Yin S, Li S, Guo Y, Wang M, et al. Hypoxia induces an endometrial cancer stem-like cell phenotype via HIF-dependent demethylation of SOX2 mRNA. Oncogenesis. 2020;9:81 pubmed publisher
|
- flow cytometry; human; 1:5; loading ...; fig s3a
| Ling C, Nishimoto K, Rolfs Z, Smith L, Frey B, Welham N. Differentiated fibrocytes assume a functional mesenchymal phenotype with regenerative potential. Sci Adv. 2019;5:eaav7384 pubmed publisher
|
- western blot; rat; 1:1000; loading ...; fig s1
| Hurtado Alvarado G, Dominguez Salazar E, Velazquez Moctezuma J, Gómez González B. A2A Adenosine Receptor Antagonism Reverts the Blood-Brain Barrier Dysfunction Induced by Sleep Restriction. PLoS ONE. 2016;11:e0167236 pubmed publisher
|
- flow cytometry; human; loading ...
| Chaudhury A, Cheema S, Fachini J, Kongchan N, Lu G, Simon L, et al. CELF1 is a central node in post-transcriptional regulatory programmes underlying EMT. Nat Commun. 2016;7:13362 pubmed publisher
|
- western blot; human; fig 2
| Yin K, Yin W, Wang Y, Zhou L, Liu Y, Yang G, et al. MiR-206 suppresses epithelial mesenchymal transition by targeting TGF-? signaling in estrogen receptor positive breast cancer cells. Oncotarget. 2016;7:24537-48 pubmed publisher
|
- immunohistochemistry; human; fig 1
| Fraveto A, Cardinale V, Bragazzi M, Giuliante F, De Rose A, Grazi G, et al. Sensitivity of Human Intrahepatic Cholangiocarcinoma Subtypes to Chemotherapeutics and Molecular Targeted Agents: A Study on Primary Cell Cultures. PLoS ONE. 2015;10:e0142124 pubmed publisher
|
- immunohistochemistry - paraffin section; human; fig 6
- western blot; human; loading ...; fig 3
| Zhang Y, Fan N, Yang J. Expression and clinical significance of hypoxia-inducible factor 1?, Snail and E-cadherin in human ovarian cancer cell lines. Mol Med Rep. 2015;12:3393-3399 pubmed publisher
|
- immunocytochemistry; human
| Chapnick D, Liu X. Leader cell positioning drives wound-directed collective migration in TGF?-stimulated epithelial sheets. Mol Biol Cell. 2014;25:1586-93 pubmed publisher
|
- immunocytochemistry; human; 1:100
| Findlay V, Moretz R, Wang C, Vaena S, Bandurraga S, Ashenafi M, et al. Slug expression inhibits calcitriol-mediated sensitivity to radiation in colorectal cancer. Mol Carcinog. 2014;53 Suppl 1:E130-9 pubmed publisher
|
| Ye Z, Xu S, Shi Y, Bacolla A, Syed A, Moiani D, et al. GRB2 enforces homology-directed repair initiation by MRE11. Sci Adv. 2021;7: pubmed publisher
|
| Liu M, Hancock S, Sultani G, Wilkins B, Ding E, Osborne B, et al. Snail-Overexpression Induces Epithelial-mesenchymal Transition and Metabolic Reprogramming in Human Pancreatic Ductal Adenocarcinoma and Non-tumorigenic Ductal Cells. J Clin Med. 2019;8: pubmed publisher
|
| Wang Y, Xiong H, Liu D, Hill C, Ertay A, Li J, et al. Autophagy inhibition specifically promotes epithelial-mesenchymal transition and invasion in RAS-mutated cancer cells. Autophagy. 2019;15:886-899 pubmed publisher
|
| Pliatska M, Kapasa M, Kokkalis A, Polyzos A, Thanos D. The Histone Variant MacroH2A Blocks Cellular Reprogramming by Inhibiting Mesenchymal-to-Epithelial Transition. Mol Cell Biol. 2018;38: pubmed publisher
|
| Huo Y, Li Q, Wang X, Jiao X, Zheng J, Li Z, et al. MALAT1 predicts poor survival in osteosarcoma patients and promotes cell metastasis through associating with EZH2. Oncotarget. 2017;8:46993-47006 pubmed publisher
|
| Yu J, Liang Q, Wang J, Wang K, Gao J, Zhang J, et al. REC8 functions as a tumor suppressor and is epigenetically downregulated in gastric cancer, especially in EBV-positive subtype. Oncogene. 2017;36:182-193 pubmed publisher
|
| Liu W, Qiao R, Wang D, Huang X, Li B, Wang D. UHRF1 promotes human osteosarcoma cell invasion by downregulating the expression of E‑cadherin in an Rb1‑dependent manner. Mol Med Rep. 2016;13:315-20 pubmed publisher
|
| Ghafoory S, Mehrabi A, Hafezi M, Cheng X, Breitkopf Heinlein K, Hick M, et al. Nuclear accumulation of CDH1 mRNA in hepatocellular carcinoma cells. Oncogenesis. 2015;4:e152 pubmed publisher
|
| Liu Y, Han X, Gao B. Knockdown of S100A11 expression suppresses ovarian cancer cell growth and invasion. Exp Ther Med. 2015;9:1460-1464 pubmed
|
| Ai L, Kim W, Alpay M, Tang M, Pardo C, Hatakeyama S, et al. TRIM29 suppresses TWIST1 and invasive breast cancer behavior. Cancer Res. 2014;74:4875-87 pubmed publisher
|
| Weitzenfeld P, Meron N, Leibovich Rivkin T, Meshel T, Ben Baruch A. Progression of luminal breast tumors is promoted by ménage à trois between the inflammatory cytokine TNF? and the hormonal and growth-supporting arms of the tumor microenvironment. Mediators Inflamm. 2013;2013:720536 pubmed publisher
|
| Kim K, Godarova A, Seedle K, Kim M, Ince T, Wells S, et al. Rb suppresses collective invasion, circulation and metastasis of breast cancer cells in CD44-dependent manner. PLoS ONE. 2013;8:e80590 pubmed publisher
|
| Junk D, Cipriano R, Bryson B, Gilmore H, Jackson M. Tumor microenvironmental signaling elicits epithelial-mesenchymal plasticity through cooperation with transforming genetic events. Neoplasia. 2013;15:1100-9 pubmed
|
| Yin S, Peng A, Huang L, Wang Y, Lan C, Yang N. The Phytochemical Shikonin Stimulates Epithelial-Mesenchymal Transition (EMT) in Skin Wound Healing. Evid Based Complement Alternat Med. 2013;2013:262796 pubmed publisher
|
| Bhatia S, Pilquil C, Roth Albin I, Draper J. Demarcation of stable subpopulations within the pluripotent hESC compartment. PLoS ONE. 2013;8:e57276 pubmed publisher
|
| de Sá V, Carvalho L, Gomes A, Alarcão A, Silva M, Couceiro P, et al. Role of the extracellular matrix in variations of invasive pathways in lung cancers. Braz J Med Biol Res. 2013;46:21-31 pubmed
|
| Jensen K, Patel A, Hoperia V, Larin A, Bauer A, Vasko V. Dynamic changes in E-cadherin gene promoter methylation during metastatic progression in papillary thyroid cancer. Exp Ther Med. 2010;1:457-462 pubmed
|
| Feng B, Dong T, Wang L, Zhou H, Zhao H, Dong F, et al. Colorectal cancer migration and invasion initiated by microRNA-106a. PLoS ONE. 2012;7:e43452 pubmed publisher
|
| Han J, Gao B, Jin X, Xu Z, Li Z, Sun Y, et al. Small interfering RNA-mediated downregulation of beta-catenin inhibits invasion and migration of colon cancer cells in vitro. Med Sci Monit. 2012;18:BR273-80 pubmed
|
| Richardson F, Young G, Sennello R, Wolf J, Argast G, Mercado P, et al. The evaluation of E-Cadherin and vimentin as biomarkers of clinical outcomes among patients with non-small cell lung cancer treated with erlotinib as second- or third-line therapy. Anticancer Res. 2012;32:537-52 pubmed
|
| Thomson S, Petti F, Sujka Kwok I, Mercado P, Bean J, Monaghan M, et al. A systems view of epithelial-mesenchymal transition signaling states. Clin Exp Metastasis. 2011;28:137-55 pubmed publisher
|
| Masur K, Vetter C, Hinz A, Tomas N, Henrich H, Niggemann B, et al. Diabetogenic glucose and insulin concentrations modulate transcriptome and protein levels involved in tumour cell migration, adhesion and proliferation. Br J Cancer. 2011;104:345-52 pubmed publisher
|
| Dangi Garimella S, Yun J, Eves E, Newman M, Erkeland S, Hammond S, et al. Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7. EMBO J. 2009;28:347-58 pubmed publisher
|
| Wang X, Yu D, McCaughan G, Gorrell M. Extra-enzymatic roles of DPIV and FAP in cell adhesion and migration on collagen and fibronectin. Adv Exp Med Biol. 2006;575:213-22 pubmed
|
| Ito M, Maruyama T, Saito N, Koganei S, Yamamoto K, Matsumoto N. Killer cell lectin-like receptor G1 binds three members of the classical cadherin family to inhibit NK cell cytotoxicity. J Exp Med. 2006;203:289-95 pubmed
|
| Wang X, Yu D, McCaughan G, Gorrell M. Fibroblast activation protein increases apoptosis, cell adhesion, and migration by the LX-2 human stellate cell line. Hepatology. 2005;42:935-45 pubmed
|